Definitive Contract VA74115C0021
Award Date 9/30/15
Potential Completion Date 9/29/18
Potential Value $989K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Houston, TX 77030, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs awarded a $1.15 million firm fixed-price purchase order to The University of Texas MD Anderson Cancer Center for medical physics peer review services supporting the VHA National Radiation Oncology Program Office. Under this sole-source acquisition, MD Anderson will provide periodic on-site dosimetry and quality assurance reviews, annual remote audits of treatment machine calibration, and credentialing of advanced radiation therapy techniques across 41 VHA...
- This is a definitive contract awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 6 to the University of Texas MD Anderson Cancer Center, a component of the University of Texas System doing business as MD Anderson Cancer Center. The $440,456.00 Firm Fixed Price contract is for genome sequencing services, with a completion date of September 17, 2020. The contract has no set-aside designation. MD Anderson Cancer Center is a comprehensive...
- This is a prime contract awarded by the U.S. government to the University of Texas MD Anderson Cancer Center, a component of the University of Texas System. The contract is for $6,155,674.00 and is a Definitive Contract with Cost No Fee pricing. The place of performance is Texas, USA. The contract is for biomedical (applied/exploratory) services and does not have a set-aside designation. MD Anderson Cancer Center, a comprehensive cancer treatment and research center, has received this prime...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 17, awarded a firm fixed-price purchase order for calibration services to The University of Texas MD Anderson Cancer Center on October 4, 2024. This non-competitive contract, valued at $2,762.50, represents a ratification of services to be performed at MD Anderson's Dallas, Texas location, with an ultimate completion date of May 15, 2026. The award carries no set-aside designation, reflecting MD Anderson's competitive...
- This is a delivery order issued under the National Cancer Institute's Cancer Prevention Agent Development Program 2012-2017 indefinite delivery/indefinite quantity (IDIQ) contract. The contract was awarded to The University of Texas MD Anderson Cancer Center, a component of the University of Texas System, to provide core infrastructure support for the program. The award has a ceiling value of $725,737.89 and an ultimate completion date of September 23, 2015. The contract is a cost-no-fee type...
- This is a modification to a federal contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to The University of Texas MD Anderson Cancer Center (MD Anderson). The original contract was a definitive cost-no-fee contract awarded on February 15, 2003 with a ceiling value of $8,606,292. This modification is to deobligate FY06 funds. MD Anderson, a U.S. state government entity and academic medical center, has been the prime contractor as...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a Firm Fixed Price Definitive Contract for $150,904.40 to the University of Texas MD Anderson Cancer Center, a component of the University of Texas System, for an "Invasive Mold Data Acquisition" project. The contract does not have a set-aside designation and was awarded on July 15, 2019, with a completion date of July 14, 2020. MD Anderson Cancer Center is a comprehensive cancer treatment...
- This federal contract was awarded by the Department of Health and Human Services' Food and Drug Administration to the University of Texas MD Anderson Cancer Center, a component of the University of Texas System. The contract, valued at $283,546.12, is for a study titled "Modular Application of Surface Technology for the Generation of Antigen-Specific T Cells." It is a definitive contract with a cost-no-fee pricing type, awarded on September 13, 2019 with a completion date of...
- This is a $1,686,205.95 delivery order contract awarded by the National Cancer Institute (NCI) to the University of Texas MD Anderson Cancer Center (MD Anderson) to conduct a randomized pre-surgical clinical trial evaluating alternative dosing regimens of the cancer drug exemestane in postmenopausal women with early-stage estrogen receptor-positive breast cancer. The contract is part of NCI's Cancer Prevention Agent Development Program, which supports early phase clinical research on new...
- This federal contract award, valued at $1,324,125.00, was made by the National Cancer Institute (NCI) to The University of Texas M.D. Anderson Cancer Center (MD Anderson) for a project titled "LOW-DOSE ERLOTINIB AND MESALAMINE FOR PREVENTION OF COLITIS-ASSOCIATED COLORECTAL CANCER (CAC)". The contract is a delivery order and utilizes a cost-sharing pricing type. MD Anderson is a premier academic cancer research and treatment institution in Houston, Texas, and has extensive experience...